首页> 美国卫生研究院文献>Stem Cell Research Therapy >Development of a simple procedure for the treatment of femoral head osteonecrosis with intra-osseous injection of bone marrow mesenchymal stromal cells: study of their biodistribution in the early time points after injection
【2h】

Development of a simple procedure for the treatment of femoral head osteonecrosis with intra-osseous injection of bone marrow mesenchymal stromal cells: study of their biodistribution in the early time points after injection

机译:骨内注射骨髓间充质基质细胞治疗股骨头坏死的简单方法的开发:注射后早期时间点的生物分布研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

IntroductionOsteonecrosis of the femoral head (ONFH) is a degenerative disease progressing to a femoral head (FH) collapse. Injection of osteoprogenitor cells like bone marrow mesenchymal stromal cells (BMSCs) into the FH appears to be a good therapeutic treatment. However, safety and efficacy of BMSCs to treat bone defect are the main preclinical data required for clinical application. Efficacy and the lack of risk of cell transformation after amplification of BMSCs have been extensively described. The main objectives of this study were to develop a simple and usable procedure for clinicians and control its feasibility by evaluating the biodistribution of BMSCs after injection into the FH in a large animal model. The impact of this approach was evaluated on one natural pig ONFH.
机译:引言股骨头坏死(ONFH)是一种退化性疾病,发展为股骨头(FH)塌陷。向FH注射像骨髓间质基质细胞(BMSCs)这样的骨祖细胞似乎是一种很好的治疗方法。然而,骨髓间充质干细胞治疗骨缺损的安全性和有效性是临床应用所需的主要临床前数据。已经广泛地描述了BMSCs扩增后的功效和缺乏细胞转化的风险。这项研究的主要目的是为临床医生开发一种简单实用的程序,并通过评估大型动物模型中注入FH后BMSC的生物分布来控制其可行性。评估了这种方法对一只天然猪ONFH的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号